J 2018

Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes

SOUČEK, Karel, Alice MALENOVSKÁ, Zuzana KAHOUNOVÁ, Ján REMŠÍK, Zuzana HOLUBCOVÁ et. al.

Basic information

Original name

Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes

Authors

SOUČEK, Karel (203 Czech Republic), Alice MALENOVSKÁ (203 Czech Republic), Zuzana KAHOUNOVÁ (203 Czech Republic), Ján REMŠÍK (703 Slovakia, belonging to the institution), Zuzana HOLUBCOVÁ (203 Czech Republic, belonging to the institution), Tomáš SOUKUP (203 Czech Republic), Daniela KURFÜRSTOVÁ (203 Czech Republic), Jan BOUCHAL (203 Czech Republic), Tereza SUCHANKOVÁ (203 Czech Republic), Eva SLABÁKOVÁ (203 Czech Republic) and Aleš HAMPL (203 Czech Republic, guarantor, belonging to the institution)

Edition

Journal of Assisted Reproduction and Genetics, NEW YORK, SPRINGER/PLENUM PUBLISHERS, 2018, 1058-0468

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10604 Reproductive biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.820

RIV identification code

RIV/00216224:14110/18:00101318

Organization unit

Faculty of Medicine

UT WoS

000441294700009

Keywords in English

Follicular fluid; Growth/differentiation factor-15; Follicular granulosa cells; IVF

Tags

International impact, Reviewed
Změněno: 17/12/2019 09:46, Mgr. Marie Šípková, DiS.

Abstract

V originále

The purpose of the study was to determine whether the GDF-15 is present in follicular fluid; to evaluate if there is a relation between follicular and serum levels of GDF-15 and fertility status of study subjects; and to test whether granulosa cells, oocytes, or both produce GDF-15. This study used follicular fluid (FF, serum, and oocytes obtained under informed consent from women undergoing oocyte retrieval for in vitro fertilization. It also used ovaries from deceased preterm newborns. Collection of FF and blood at the time of oocyte retrieval, ELISA and western blot were performed to determine levels and forms of GDF-15. Concentrations of GDF-15 in FF and serum, its expression in ovarian tissue, and secretion from granulosa cells were analyzed. GDF-15 concentration in FF ranged from 35 to 572 ng/ml, as determined by ELISA. Western blot analysis revealed the GDF-15 pro-dimer only in FF. Both normal healthy and cancerous granulosa cells secreted GDF-15 into culture media. Primary oocytes displayed cytoplasmic GDF-15 positivity in immunostained newborn ovaries, and its expression was also observed in fully grown human oocytes. To the best of our knowledge, this is the first documentation of cytokine GDF-15 presence in follicular fluid. Its concentration was not associated with donor/patient fertility status. Our data also show that GDF-15 is expressed and inducible in both normal healthy and cancerous granulosa cells, as well as in oocytes.

Links

EE2.3.20.0185, research and development project
Name: Centrum analýz a modelování tkání a orgánů
GA15-11707S, research and development project
Name: Centrosomální abnormality u lidských pluripotentních kmenových buněk.
Investor: Czech Science Foundation
NV15-33999A, research and development project
Name: Vývoj nových nízkomolekulárních protinádorových léčiv na principu syntetické letality